Prof. Dr from Guilin Medical University, China
Jin Jiamin is a dedicated research fellow at Guilin Medical College, Basic Medical College. With a strong foundation in veterinary and medical sciences, he has been actively engaged in cutting-edge research in cancer biology and immunology. His work primarily focuses on the mechanisms of ubiquitin-specific isopeptidases and their role in cancer progression, particularly in colorectal and oral cancer. Over the years, he has contributed significantly to various national and international research projects, working both independently and collaboratively with esteemed institutions such as Indiana University. His expertise in molecular biology, cancer immunology, and targeted drug therapy has led to numerous publications in high-impact journals. Jiamin has also secured substantial funding for his research, contributing to advancements in the understanding of cancer treatment. His commitment to scientific innovation is evident in his leadership in multiple research projects and his extensive collaborations with leading researchers worldwide. With a strong academic background and a wealth of experience in experimental research, he continues to push the boundaries of medical science, striving to develop new therapeutic strategies for cancer treatment and beyond.
Professional Profile
Education
Jin Jiamin has an extensive academic background in medical and veterinary sciences. He earned his Ph.D. in Developmental Biology from Northeast Forestry University (2015–2019), where he focused on molecular mechanisms in disease progression. Before that, he obtained a Master’s degree in Basic Veterinary Medicine from Northeast Agricultural University (2010–2013), where he gained in-depth knowledge of animal physiology and pathology. His academic journey began with a Bachelor’s degree in Animal Medicine (Preventive Veterinary Medicine) from Heilongjiang Bayi Agricultural Reclamation University (2004–2008), where he developed a strong foundation in veterinary medicine and preventive healthcare. Throughout his academic career, Jiamin has consistently demonstrated a passion for medical research, leading to his specialization in cancer biology and immunology. His education provided him with interdisciplinary expertise, enabling him to integrate veterinary and medical sciences into his research. By bridging these fields, he has contributed significantly to the understanding of disease mechanisms, particularly in cancer progression. His rigorous training in developmental biology, veterinary medicine, and molecular research has equipped him with the skills necessary to lead innovative studies and advance medical science through his scholarly contributions and experimental research.
Professional Experience
Jin Jiamin has accumulated valuable professional experience in both national and international institutions. Since July 2019, he has been serving as a researcher at Guilin Medical College, Basic Medical College, where he focuses on cancer research and molecular biology. Prior to this, he expanded his research experience through an international collaboration at the School of Medicine, Indiana University, USA (2017–2019), where he worked on advanced medical research projects. His professional journey has been marked by active participation in groundbreaking research, exploring molecular mechanisms that contribute to cancer progression. Throughout his career, Jiamin has demonstrated expertise in experimental design, data analysis, and laboratory techniques, significantly contributing to the fields of oncology and immunology. His role as a research fellow has allowed him to lead various research projects, collaborate with esteemed scientists, and mentor emerging researchers. His ability to work across different medical disciplines and his experience in high-impact research environments have made him a key figure in cancer biology research. His professional experience reflects a deep commitment to scientific discovery and an ongoing pursuit of innovative therapeutic approaches.
Research Interests
Jin Jiamin’s research interests lie at the intersection of cancer biology, immunology, and molecular medicine. His primary focus is on understanding the role of ubiquitin-specific isopeptidases in regulating tumor progression and immune responses. He is particularly interested in colorectal and oral cancer, investigating how specific cellular mechanisms contribute to cancer metastasis and resistance to therapy. His work also delves into the development of novel drug targets for cancer treatment, exploring pathways such as the Borealin-Src signaling pathway and the ST2-positive Treg cells in tumor environments. Additionally, he has explored drug delivery systems for colon cancer treatment, incorporating nanotechnology to enhance therapeutic efficacy. His research extends to the immunomodulatory effects of phytoestrogens, contributing to advancements in transplantation medicine. By combining molecular biology, immunology, and pharmacology, he aims to develop innovative cancer therapies that improve patient outcomes. His work has significant implications for cancer diagnosis, treatment, and personalized medicine, making valuable contributions to the medical research community.
Research Skills
Jin Jiamin possesses a diverse set of research skills that contribute to his success as a medical scientist. His expertise includes molecular biology techniques such as Western blotting, PCR, immunohistochemistry, and flow cytometry. He is proficient in cell culture, gene editing, and protein analysis, allowing him to investigate cellular mechanisms in disease progression. His skills extend to computational biology, where he employs bioinformatics tools to analyze genetic and proteomic data. Additionally, Jiamin has experience in nanotechnology-based drug delivery systems, exploring their applications in targeted cancer therapies. His background in experimental oncology enables him to design and execute preclinical studies, assessing drug efficacy and tumor responses. He is also skilled in grant writing and project management, having successfully secured research funding from national and international agencies. His ability to integrate laboratory research with clinical applications highlights his interdisciplinary approach to medical science. Through his technical expertise and innovative methodologies, Jiamin continues to contribute to the advancement of cancer research and molecular medicine.
Awards and Honors
Jin Jiamin has received multiple awards and recognitions for his contributions to cancer research and molecular medicine. His work has been published in high-impact journals, reflecting his scientific excellence and research impact. As a co-first author and co-corresponding author, he has contributed to groundbreaking studies in oncology, immunology, and drug discovery. His notable publications include studies on the role of ubiquitin-specific proteases in cancer, the effects of vitamin D and neferine on colorectal cancer, and novel drug delivery systems for cancer therapy. Additionally, he has been a recipient of prestigious research grants from the National Natural Science Foundation of China, supporting his investigations into tumor progression mechanisms. His role in securing substantial research funding underscores his leadership in the scientific community. His awards and academic achievements highlight his dedication to medical research, reinforcing his status as an influential researcher in cancer biology and therapeutic innovations.
Conclusion
Jin Jiamin is a distinguished research fellow with a strong academic and professional background in cancer biology, immunology, and molecular medicine. His research has significantly contributed to understanding the molecular mechanisms underlying cancer progression, with a particular focus on colorectal and oral cancers. His expertise in ubiquitin-specific isopeptidases, immunoregulation, and targeted drug therapies has led to numerous high-impact publications and prestigious research funding. His work not only advances fundamental scientific knowledge but also has practical implications for developing new cancer treatments. As a researcher, he continues to explore innovative therapeutic strategies, integrating molecular biology, pharmacology, and nanotechnology. His international research collaborations and leadership in multiple research projects highlight his dedication to advancing medical science. With a commitment to scientific excellence and a passion for improving cancer treatments, Jin Jiamin remains a key figure in oncology research, shaping the future of cancer therapy and precision medicine.
Publication Top Notes
1.Designing novel Au(III) complexes based on the structure of diazepam: Achieving a multiaction mechanism against glioma.
- Authors: Li, Y., Liu, H., Fang, R., Chen, J., & Zhang, J.
- Year: 2025